A型主动脉夹层术后行分支支架主动脉弓腔内修复的适用性分析
本研究为双中心回顾性研究,评估A型急性主动脉夹层术后残留弓部病变患者使用两种分支支架行主动脉弓腔内修复(Ar-TEVAR)的解剖适用性。共纳入119例(25.6%)患者,总体适用率为49.6%,Nexus单分支支架适用率31.9%,RelayBranch双分支支架适用率35.3%。近端锚定区不足是主要排除原因,常与初次手术可改变因素相关。
要点
- A型夹层术后约半数患者解剖上适合分支支架行弓部腔内修复。
- Nexus与RelayBranch支架适用率分别为31.9%和35.3%,仅17.6%两者均适用。
- 近端锚定区不足是主要排除原因,多与升主动脉移植物过短或扭结有关。
核心结论
- A型主动脉夹层术后残留弓部病变患者中约一半适合使用Nexus或RelayBranch支架行Ar-TEVAR。
- 初次手术中可改变的因素常导致后续腔内修复不适用,提示需优化外科策略以保留未来腔内治疗选项。
研究设计与样本
- 回顾性双中心研究,评估2012年1月至2023年9月间因A型急性主动脉夹层行手术且符合纳入标准的患者。
- 纳入标准为既往手术限于升主动脉和/或半弓置换,并有高质量出院前CT扫描。
- 由两名独立医师依据制造商规格分析CT,评估Nexus单分支支架和RelayBranch双分支支架的适用性。
主要发现
- 465例A型夹层手术患者中119例(25.6%)纳入分析。
- 总体Ar-TEVAR可行59例(49.6%)。
- Nexus适用率31.9%,RelayBranch适用率35.3%,两者均适用仅21例(17.6%)。
- 近端锚定区不足是Nexus不适用48.1%和RelayBranch不适用68.8%的主要原因。
临床怎么用
- 对于A型夹层术后残留弓部病变患者,可评估分支支架Ar-TEVAR的解剖适用性。
- 初次手术时应考虑升主动脉移植物的长度和形态,避免过短或扭结,以保留未来腔内修复的锚定区。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Endovascular aortic arch repair (Ar-TEVAR) may be a viable option for patients with residual arch pathology after surgery for type A acute aortic dissection (ATAAD). However, anatomical limitations can hinder its suitability. The primary outcome of this retrospective, dual-centre study aimed to assess the suitability of Ar-TEVAR using 2 branched devices in patients with prior ATAAD repair. METHODS: Patients who underwent surgery for ATAAD at 2 centres between January 2012 and September 2023 were evaluated. The inclusion criteria were prior surgery limited to ascending and/or hemiarch replacement and the availability of a high-quality predischarge computed tomography (CT) scan. Two independent physicians analysed the CT scans to assess suitability for the single-branch NEXUS Aortic Arch Stent Graft System and the double-branch RelayBranch Thoracic Stent-Graft System, based on manufacturers' specifications. RESULTS: Of 465 patients who underwent surgery for ATAAD, 119 (25.6%) were included. Overall, Ar-TEVAR was feasible in 59 patients (49.6%). Device-specific suitability rates were 31.9% for Nexus and 35.3% for RelayBranch, with only 21 patients (17.6%) eligible for both. An inadequate proximal landing zone, often due to surgically modifiable factors such as a too-short or kinked ascending graft, was the primary reason for ineligibility in 48.1% of Nexus cases and 68.8% of RelayBranch cases. CONCLUSIONS: Approximately half of patients with residual aortic arch pathology after ATAAD surgery are eligible for Ar-TEVAR with Nexus and RelayBranch systems. Surgically modifiable factors at the time of the index procedure frequently contribute to ineligibility, highlighting the need for surgical strategies that optimize future endovascular options.
引用
- D'Onofrio A, Caraffa R, Cibin G, et al. Suitability Analysis of 2 Devices for Endovascular Aortic Arch Repair Following Type A Aortic Dissection Surgery. Eur J Cardiothorac Surg. 2026. PMID: 41803625. doi:10.1093/ejcts/ezag115
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。